DEEPX-B IPO Draws 1,073x Oversubscription in Hong Kong

Edgen Stock

·Mar 29 2026, 05:14

Share to

Share to

Copy link

Key Takeaways

Chinese medical imaging firm DEEPX-B (02526.HK) saw overwhelming retail demand for its Hong Kong initial public offering, signaling strong investor appetite. The offering was priced below the midpoint of its marketed range, raising HKD720 million in net proceeds ahead of its market debut.

The Hong Kong public offering was oversubscribed by 1,073.37 times, while the international tranche was oversubscribed by a more modest 3.45 times.
Shares were priced at HKD99 each, raising net proceeds of approximately HKD720 million for the company.
Demand was so intense that the probability of a retail investor securing a single lot of 50 shares was only 3%, with a 70,000-share subscription required to guarantee an allocation.

IPO Attracts 1,073x Retail Oversubscription

DEEPX-B (02526.HK), a medical device company from Mainland China, reported massive investor demand for its Hong Kong initial public offering. The retail portion of the IPO was oversubscribed by 1,073.37 times, a clear signal of intense public interest. This demand contrasts with the institutional tranche, which was oversubscribed by 3.45 times. The high demand from retail investors resulted in a low allocation probability, with the chance of securing one lot of 50 shares standing at just 3%. To guarantee an allocation of a single lot, investors needed to subscribe for 70,000 shares.

Final Price Set at HKD99 to Raise HKD720 Million

The final offer price was set at HKD99 per share, which is below the midpoint of the initial indicative range of HKD95.6 to HKD112.5. From the global offering of 7.9992 million shares, the company will receive net proceeds of approximately HKD720 million. DEEPX-B specializes in developing medical imaging products and services. The listing, solely sponsored by Huatai International, is scheduled to commence on the Hong Kong Stock Exchange on Monday, the 30th.